Agilent Technologies (A)
(Delayed Data from NYSE)
$142.92 USD
+0.39 (0.27%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $142.86 -0.06 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$142.92 USD
+0.39 (0.27%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $142.86 -0.06 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Zacks News
Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.
Can Strong Cloud Growth Propel Alibaba's (BABA) Q3 Earnings?
by Zacks Equity Research
Alibaba Group Holding's (BABA) revenue segments, namely cloud computing & core commerce, are likely to have performed well in the fiscal third quarter.
Fortive (FTV) Earnings & Revenues Surpass Estimates in Q4
by Zacks Equity Research
Fortive (FTV) reports strong Q4 results, wherein both earnings and revenues surpassed the Zacks Consensus Estimate.
How to Time the Markets Like an Investing Pro - January 29, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Timing the Market, Is it Possible? - January 10, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Why Is Agilent (A) Up 5.4% Since Last Earnings Report?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Market Timing Secrets No One Talks About - December 17, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Agilent (A) Earnings and Revenues Surpass Estimates in Q4
by Zacks Equity Research
Agilent (A) reports solid fiscal fourth-quarter results driven by strength in all its revenue segments.
Agilent Technologies (A) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of 3.49% and 2.98%, respectively, for the quarter ended October 2019. Do the numbers hold clues to what lies ahead for the stock?
Agilent (A) Hikes Quarterly Dividend to Reward Shareholders
by Zacks Equity Research
Agilent (A) hikes dividend to 18 cents per share in a bid to reward its shareholders.
Yes, You Can Time the Market. Find out How - November 21, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Agilent (A) Gears Up for Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Agilent's (A) leadership position and strength in revenue segments are likely to reflect on fiscal fourth-quarter results.
Agilent Technologies (A) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Market-Beating Sector ETFs Year to Date
by Sanghamitra Saha
Despite occasional trade tensions, U.S. equity gauges have added solid gains this year. But these sector ETFs handily beat the soaring broader market.
When Does Market Timing Actually Work? - November 01, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Electronics Testing Equipment Outlook: Solid Demand Ahead
by Zacks Equity Research
Increasing usage of electronic testing equipment and solutions in the devices required in every major sector continues to be a tailwind for Zacks Electronics - Testing Equipment industry.
Advanced Energy (AEIS) Supplies Power to Grenzebach's Lab
by Zacks Equity Research
Advanced Energy Industries (AEIS) collaborates with Grenzebach Group to supply power to the latter's new lab.
Cypress Looks to Gain Traction With New USB-C Controller
by Zacks Equity Research
Cypress Semiconductor (CY) launches an advanced USB-C controller called ACG1F to make the most of the opportunities in the market.
Trimble Strengthens Agriculture Portfolio with Weedseeker 2
by Zacks Equity Research
Trimble (TRMB) launches an Advanced Spray System called Weedseeker 2 with an aim to gain traction among farmers.
Agilent Boosts Spectroscopy Share With New Facility in UK
by Zacks Equity Research
Agilent Technologies (A) opens a new facility in U.K. for research and development in the field of spectroscopy.
How to Time the Markets Like an Investing Pro - October 10, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Bruker To Buy Freiberg Instruments' Magnettech EPR Business
by Zacks Equity Research
The Freiberg Instruments' Magnettech EPR business acquisition is expected to boost Bruker's (BRKR) BioSpin business by complementing its existing range of EPR offerings.
4 Stocks to Focus on Global Biotechnology Reagents Market
by Zacks Equity Research
Increased use of reagents in the field of research, bioscience and genetics is pushing the biotechnology reagents market higher.
Simple Market Timing Strategies That Work - September 17, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
What Makes Agilent (A) a New Buy Stock
by Zacks Equity Research
Agilent (A) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Agilent (A) Up 11.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.